- Home
- RCKT vs TTGT Comparison
RCKT vs TTGT Comparison
Compare RCKT & TTGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | TTGT |
|---|---|---|
| Founded | 1999 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.9M | 352.9M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | RCKT | TTGT |
|---|---|---|
| Price | $3.51 | $5.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $29.12 | $11.25 |
| AVG Volume (30 Days) | ★ 1.9M | 322.1K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $446,514,000.00 |
| Revenue This Year | N/A | $74.33 |
| Revenue Next Year | N/A | $3.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 71.55 |
| 52 Week Low | $2.19 | $4.63 |
| 52 Week High | $13.35 | $20.84 |
Technical Indicators
Market Signals| Indicator | RCKT | TTGT |
|---|---|---|
| Relative Strength Index (RSI) | 55.01 | 46.99 |
| Support Level | $3.19 | $4.92 |
| Resistance Level | $3.60 | $5.82 |
| Average True Range (ATR) | 0.19 | 0.35 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 70.65 | 26.38 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About TTGT TechTarget Inc.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. Through its B2B first-party data and an end-to-end portfolio of data-driven solutions, it services the full B2B product lifecycle for customers from, messaging, and content development to in-market activation via brand, demand generation, purchase intent data, and sales enablement from R&D to ROI.